The top spot in the world’s best-selling drug list may not be a suspense in the short term, according to a report by EvaluatePharma, a market research firm. In 2018, […]
Olaparib, also known as AZD-2281 or KU-59436, is a small molecule inhibitor of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to […]
December 7, 2017 – Researchers from Brock University have found that certain amounts of lithium in drinking water may slow death rates in people with Alzheimer’s disease, according to a […]
December 7, 2017 – Insomnia might be an early sign of disorder for brain-associated diseases, according to the latest findings published in the neurological journal The Lancet Neurology. Researchers from […]
On Oct. 18, 2017, the Food and Drug Administration (FDA)’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has unanimously voted 16-0 to support the approval of Novo Nordisk’s semaglutide, a […]
Diabetes can be caused by multiple factors, but we still can take certain measures to lower the risks of developing diabetes. In a new research published in Diabetologia (the journal of the […]
Maintenance of DNA topology is critical for normal DNA replication, transcription and repair in eukaryotic cells. One family of enzymes, the topoisomerases, is essential for this process. Eukaryotic topoisomerase I […]
The main control measures in cotton fields in China include chemical control, cultural control (e.g., intercropping with trap crops), physical control (e.g., light traps and sticky traps), and biological control […]
With upgrading of technologies and better understanding of diseases, the death rate caused by cancers is considerably decreased. According to the 2017 Cancer Progress Report released by the American Association […]
In 2016, the US FDA approved 22 new drugs, the number is the lowest for the ten years. In the first half of 2017, the US FDA had approved 23 new drugs, […]